214 related articles for article (PubMed ID: 33621853)
1. c-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells.
Dúcka M; Kučeríková M; Trčka F; Červinka J; Biglieri E; Šmarda J; Borsig L; Beneš P; Knopfová L
Neoplasia; 2021 Mar; 23(3):326-336. PubMed ID: 33621853
[TBL] [Abstract][Full Text] [Related]
2. Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.
Knopfová L; Biglieri E; Volodko N; Masařík M; Hermanová M; Glaus Garzón JF; Dúcka M; Kučírková T; Souček K; Šmarda J; Beneš P; Borsig L
Oncogene; 2018 Feb; 37(8):1020-1030. PubMed ID: 29084208
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
Nicot C; Mahieux R; Pise-Masison C; Brady J; Gessain A; Yamaoka S; Franchini G
Mol Cell Biol; 2001 Nov; 21(21):7391-402. PubMed ID: 11585920
[TBL] [Abstract][Full Text] [Related]
4. HER2 Overexpression Triggers an IL1α Proinflammatory Circuit to Drive Tumorigenesis and Promote Chemotherapy Resistance.
Liu S; Lee JS; Jie C; Park MH; Iwakura Y; Patel Y; Soni M; Reisman D; Chen H
Cancer Res; 2018 Apr; 78(8):2040-2051. PubMed ID: 29382706
[TBL] [Abstract][Full Text] [Related]
5. Sufentanil inhibits the metastasis and immune response of breast cancer via mediating the NF-κB pathway.
Li M; Gu K; Kong Q; Wang G; Gu J
Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):663-671. PubMed ID: 37358084
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
7. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro.
Duan M; Hu F; Li D; Wu S; Peng N
Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571
[TBL] [Abstract][Full Text] [Related]
8. Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modification.
Pham LV; Zhou HJ; Lin-Lee YC; Tamayo AT; Yoshimura LC; Fu L; Darnay BG; Ford RJ
J Biol Chem; 2008 Feb; 283(8):5081-9. PubMed ID: 18093978
[TBL] [Abstract][Full Text] [Related]
9. The Interaction between Macrophages and Triple-negative Breast Cancer Cells Induces ROS-Mediated Interleukin 1α Expression to Enhance Tumorigenesis and Metastasis.
Hao M; Huang B; Wu R; Peng Z; Luo KQ
Adv Sci (Weinh); 2023 Oct; 10(29):e2302857. PubMed ID: 37551997
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
Bendinelli P; Matteucci E; Maroni P; Desiderio MA
Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
[TBL] [Abstract][Full Text] [Related]
11. Activation of lncRNA lnc-SLC4A1-1 induced by H3K27 acetylation promotes the development of breast cancer via activating CXCL8 and NF-kB pathway.
Yi T; Zhou X; Sang K; Huang X; Zhou J; Ge L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3765-3773. PubMed ID: 31556319
[TBL] [Abstract][Full Text] [Related]
12. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
[TBL] [Abstract][Full Text] [Related]
13. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
14. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M
J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143
[TBL] [Abstract][Full Text] [Related]
15. Tumor-promoting properties of enolase-phosphatase 1 in breast cancer via activating the NF-κB signaling pathway.
Bu Y; Hao J; He J; Li X; Liu Y; Ma L
Mol Biol Rep; 2023 Feb; 50(2):993-1004. PubMed ID: 36378417
[TBL] [Abstract][Full Text] [Related]
16. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
[TBL] [Abstract][Full Text] [Related]
18. FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression.
Miao L; Zhuo Z; Tang J; Huang X; Liu J; Wang HY; Xia H; He J
Clin Transl Med; 2021 Apr; 11(4):e395. PubMed ID: 33931964
[TBL] [Abstract][Full Text] [Related]
19. Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.
Tsubaki M; Komai M; Fujimoto S; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
J Exp Clin Cancer Res; 2013 Sep; 32(1):62. PubMed ID: 24011086
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.
Li CW; Xia W; Huo L; Lim SO; Wu Y; Hsu JL; Chao CH; Yamaguchi H; Yang NK; Ding Q; Wang Y; Lai YJ; LaBaff AM; Wu TJ; Lin BR; Yang MH; Hortobagyi GN; Hung MC
Cancer Res; 2012 Mar; 72(5):1290-300. PubMed ID: 22253230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
